Telix Pharmaceuticals Limited Successfully Completes $50 Million Oversubscribed Initial Public Offering
MELBOURNE, Australia, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited ("Telix", the "Company"), an Australian biopharmaceutical company focused on the development of diagnostic and therapeutic products based on targeted radiopharmaceuticals or "molecularly-targeted radiation" (MTR), has successfully raised $50 million following the close of its fully underwritten Initial Public Offering (IPO). The IPO was strongly supported by institutional investors internationally and domestically, as well as by retail investors in Australia.
Telix's shares are due to begin trading on the Australian Securities Exchange (ASX) on 15th November 2017 under the ticker code TLX. The IPO, with a total of 77.0 million shares issued at $0.65 per share, gives Telix a market capitalisation of $128 million. The IPO was fully underwritten by the Lead Managers, Taylor Collison Limited and Wilsons Corporate Finance Limited.
The IPO was also strongly supported by existing shareholders, which include both industry partners and domestic institutional investors such as Acorn Capital, CVC, Monash Investors, Viburnum Funds, Alium Capital Management and Allan Moss. Fidelity International is a cornerstone investor in the IPO and will hold approximately 10% of the issued capital of the Company upon completion of the IPO.
Telix Co-Founder and CEO Dr. Christian Behrenbruch said the company was delighted with the strong support from investors.
"We would like to thank both existing and new investors for their support of the IPO and look forward to sharing the next phase of our journey with our shareholders. With established clinical data and several well-defined value inflection points in the coming months, this financing will enable Telix to deliver significant clinical and commercial outcomes."
Telix Co-Founder and Chief Medical Officer Dr. Andreas Kluge noted, "We started the Telix journey over two years ago with the goal of creating momentum in a field of medicine that has great clinical potential but is only just starting to hit its commercial stride. We have built a company that we believe will have meaningful patient impact in disease areas with major unmet diagnostic and therapeutic need."
Proceeds from the IPO will provide capital to fund the development and completion of clinical trials for Telix's pipeline in renal (kidney), prostate and brain cancer (glioblastoma), and assist the Company to complete multiple clinical and product development milestones over the next 24 months.
Telix Pharmaceuticals Limited
Dr Christian Behrenbruch
Investor and Media Relations
Tel: +61 (3) 9866 4722
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Telix Pharmaceuticals Limited via Globenewswire
Om Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York
+1 212 401 8700http://www.nasdaqomx.com
NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.
Følg saker fra Nasdaq GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Nasdaq GlobeNewswire
The IASLC 19th World Conference on Lung Cancer Arrives in Toronto, Canada21.8.2018 18:43 | Pressemelding
DENVER, Aug. 21, 2018 (GLOBE NEWSWIRE) -- What: The International Association for the Study of Lung Cancer (IASLC) presents the IASLC 19th World Conference on Lung Cancer (WCLC) on September 23-26, 2018, in Toronto, Canada. The WCLC is the world’s largest meeting dedicated solely to lung cancer and other thoracic malignancies, and is expected to convene over 7,000 researchers, physicians, specialists, patients, advocates and industry members from around the world. The WCLC’s scientific program features a line-up of global leaders in the field. Presentations focus on cutting-edge science, including the latest breakthroughs in targeted therapies and immunotherapies; advances in screening, early detection and staging; prevention and smoking cessation efforts; patient advocacy initiatives; and much more. Collaboration across disciplines and borders is a meeting highlight. The WCLC’s scientific program is available to review online. When and Where: September 23-26, 2018, Metro Toronto Conve
TrueCommerce Announces Microsoft Dynamics 365 Business Central Integration21.8.2018 16:00 | Pressemelding
End-to-end, cloud-based EDI solution offers immediate connectivity with retailers, marketplaces, dropship vendor programs and ecommerce storefronts PITTSBURGH, Aug. 21, 2018 (GLOBE NEWSWIRE) -- TrueCommerce, a global provider of trading partner connectivity and integration solutions, today announced its integration with Microsoft Dynamics 365 Business Central, an all-in-one business management solution for small to midsize companies. The new TrueCommerce integration makes it simple and affordable for organizations on the Business Central platform to connect and integrate their sales channels and streamline fulfillment. “The Microsoft Dynamics 365 Business Central platform offers an end-to-end view of sales, purchasing, inventory and customer interactions within one platform,” said TrueCommerce president Ross Elliott. “TrueCommerce extends that view outside the four walls of an enterprise by integrating sales, purchasing, inventory, and fulfillment interactions with supply chain partici
Kasha Cacy Appointed Global CEO of Engine21.8.2018 14:30 | Pressemelding
NEW YORK, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Data-driven marketing solutions company Engine today announced the appointment of Kasha Cacy as the company’s global chief executive officer, a new position. Effective Sept. 4, Cacy will oversee Engine’s 17 offices across North America, the UK, Europe and Asia-Pacific, leading the company’s marketing solutions offering, from insights and content to distribution and technology. Cacy joins Engine from UM, the full-service marketing and media agency network of IPG Mediabrands, where she served as U.S. CEO. She will be based out of Engine’s headquarters in New York, and will report to Engine Executive Chairman Paul Caine. “I’m delighted to welcome Kasha to the Engine family,” said Caine. “Her talent, drive and vision will be tremendous assets as we enter an exciting time for the company and our clients. Kasha has deep expertise across media, data, marketing and consulting. She will be key in leading Engine as we build upon our differentiated offe
SoftServe Heats Up the Cloud Market with New Dedicated Go-to-Market Strategy with Google Cloud21.8.2018 13:00 | Pressemelding
AUSTIN, Texas, Aug. 21, 2018 (GLOBE NEWSWIRE) -- SoftServe, a digital authority and consulting company, announces a new go-to-market strategy with Google Cloud, as part of SoftServe’s recent acknowledgement as a Google Cloud Premier Partner. SoftServe joined the Google Cloud Partner Program in April 2017 and has since completed extensive technical training, successfully delivered numerous complex implementations on GCP and met rigorous evaluations to achieve Google Cloud’s highest partner status. “As part of the growing Google Cloud partner ecosystem, achieving the Premier status is a testament to SoftServe’s commitment to innovation that moves the needle for our clients every day on their digital journey,” said Todd Lenox, Vice President, Digital Services Group at SoftServe. “Our continued partnership with Google Cloud enables us to provide cutting-edge cloud expertise for the future.” As part of the premier partnership, SoftServe is heating up the cloud market by executing well-coord
SolarWinds Broadens Systems Portfolio with Unified Infrastructure Management Enhancements21.8.2018 12:30 | Pressemelding
Portfolio enhancements to be showcased at VMworld 2018 US AUSTIN, Texas, Aug. 21, 2018 (GLOBE NEWSWIRE) -- SolarWinds, a leading provider of powerful and affordable IT management software, today unveiled a wave of updates to the SolarWinds® Orion® Platform and its product portfolio. The enhancements span multiple products, with SolarWinds debuting the latest versions of Server & Application Monitor (SAM), Virtualization Manager (VMAN), Storage Resource Monitor (SRM), and introducing SolarWinds Server Configuration Monitor (SCM). The enhancements enable unified infrastructure management for technology practitioners, designed to help them quickly identify performance issues and correlations between all layers of the technology stack. “Technology professionals managing increasingly complex and distributed IT environments require monitoring tools that transcend the challenges introduced by hybrid IT,” said Christoph Pfister, executive vice president of products, SolarWinds. “The portfolio
Bombardier Wins Contract to Provide up to 50 TRAXX MS3 Locomotives to CD Cargo21.8.2018 12:21 | Pressemelding
Order marks the TRAXX 3 platform’s arrival in the Central, Eastern and Southeastern European markets First call off for 10 high-performance TRAXX Multi-System locomotives will strengthen hauling capacity and reduce energy consumption BERLIN, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Note to editors: To view the photos associated with this press release, please visit the following links: http://www.globenewswire.com/NewsRoom/AttachmentNg/6de34b48-f11a-498d-9865-4deb67548b01 http://www.globenewswire.com/NewsRoom/AttachmentNg/fb82fb71-44cf-48c2-aa37-1d277fd35ae8 Rail technology leader, Bombardier Transportation and CD Cargo, the freight subsidiary of Czech Railways, have signed a purchase agreement for up to 50 of the newest generation of BOMBARDIER TRAXX Multi-System1 (MS) locomotives. This first call-off is for 10 TRAXX MS3 locomotives. Ivan Bednárik, Chairman of the Board of Directors, CD Cargo, said, “The new TRAXX MS3 locomotive will be the most modern in our fleet. Its powerful traction and
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom